Increased pineal Fdopa uptake is related to severity of Parkinson's disease – A PET study

We investigated regional L‐3,4‐dihydroxy‐6‐[18F]fluoro‐phenylalanine (Fdopa) uptake within the pineal gland using co‐registration of Fdopa PET and MRI images. Data from 12 early Parkinson's disease (PD) and 9 advanced PD patients were compared with those from 13 age‐matched healthy controls. We found a significant increase of Fdopa influx constants (Ki) and relative Fdopa tracer activity in the pineal gland of PD patients. Additionally, significant correlations were found between Ki and the Hoehn and Yahr (H&Y) scores, and between the relative Fdopa activity and the parameters disease duration, H&Y disease score and Unified Parkinson's Disease Rating Scale (UPDRS). Our studies in patients with PD indicate a participation of extrastriatal dopaminergic structures within the scope of pathophysiological processes in PD. The result may be explained as a compensatory upregulation of monoaminergic transmitter systems outside the basal ganglia. Increased Fdopa uptake in the pineal gland may reflect pineal dysfunction in PD patients.

[1]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[2]  Karl J. Friston,et al.  Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study. , 1999, Brain : a journal of neurology.

[3]  V. Oikonen,et al.  Striatal 6‐[18F]fluorodopa accumulation after combined inhibition of peripheral catechol‐O‐methyltransferase and monoamine oxidase type B: Differing response in relation to presynaptic dopaminergic dysfunction , 1997, Synapse.

[4]  J. Eberling,et al.  PET studies of functional compensation in a primate model of Parkinson's disease , 1997, Neuroreport.

[5]  Á. Pascual-Leone,et al.  Melatonin levels in Parkinson's disease: Drug therapy versus electrical stimulation of the internal globus pallidus , 1997, Experimental Gerontology.

[6]  Y. Agid,et al.  Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra , 1996, Brain Research.

[7]  Francisco Vives,et al.  Melatonin‐dopamine interaction in the striatal projection area of sensorimotor cortex in the rat , 1996, Neuroreport.

[8]  J. Haycock,et al.  Striatal 3,4‐dihydroxyphenylalanine decarboxylase in aging: Disparity between postmortem and positron emission tomography studies? , 1995, Annals of neurology.

[9]  U Pietrzyk,et al.  An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  Alan C. Evans,et al.  Elevated dopa decarboxylase activity in living brain of patients with psychosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  N. Volkow,et al.  Slow recovery of human brain MAO B after L‐Deprenyl (Selegeline) withdrawal , 1994, Synapse.

[12]  G. Oxenkrug,et al.  Calcium, calcification, and melatonin biosynthesis in the human pineal gland: A postmortem study into age‐related factors , 1994, Journal of pineal research.

[13]  K Wienhard,et al.  The ECAT EXACT HR: Performance of a New High Resolution Positron Scanner , 1994, Journal of computer assisted tomography.

[14]  F. Waldhauser,et al.  Circadian secretion pattern of melatonin in de novo Parkinsonian patients: evidence for phase-shifting properties of l-dopa , 1993, Journal of neural transmission. Parkinson's disease and dementia section.

[15]  A. Gjedde,et al.  6-[18F]fluoro-l-DOPA Metabolism in Living Human Brain: A Comparison of Six Analytical Methods , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  S Grootoonk,et al.  Performance Evaluation of the Positron Scanner ECAT EXACT , 1992, Journal of computer assisted tomography.

[17]  M. Bannon,et al.  Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[18]  B. Bloch,et al.  Aromatic l-amino-acid decarboxylase (DOPA decarboxylase) gene expression in dopaminergic and serotoninergic cells of the rat brainstem , 1991, Neuroscience Letters.

[19]  C D Marsden,et al.  The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. , 1990, Brain : a journal of neurology.

[20]  C. Patlak,et al.  Nigrostriatal function in humans studied with positron emission tomography , 1989, Annals of neurology.

[21]  H. L. Wiener,et al.  Chronic L-deprenyl-induced up-regulation of the dopamine uptake carrier. , 1989, European journal of pharmacology.

[22]  R. Pfeiffer,et al.  Status of Dopamine in Bovine Pineal Glands and the Stimulation of N‐Acetyltransferase Activity by D2‐Dopaminergic Receptor Agonists in the Rat Pineal Glands in Culture , 1989, Journal of pineal research.

[23]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[24]  C. Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  C. Nahmias,et al.  Dopamine visualized in the basal ganglia of living man , 1983, Nature.

[26]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  R. Wurtman,et al.  Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model. , 1982, Israel journal of medical sciences.

[28]  K. Fuxe,et al.  Compensatory bilateral changes in dopamine turnover after striatal kainate lesion , 1980, Nature.

[29]  J. Michenfelder.  Blood–Brain Barrier in Physiology and Medicine , 1977 .

[30]  Y. Agid,et al.  Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. , 1973, Nature: New biology.

[31]  T. Deguchi,et al.  Induction and superinduction of serotonin N-acetyltransferase by adrenergic drugs and denervation in rat pineal organ. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[32]  O. Hornykiewicz,et al.  OCCURRENCE AND DISTRIBUTION OF AROMATIC l‐AMINO ACID (l‐DOPA) DECARBOXYLASE IN THE HUMAN BRAIN , 1972, Journal of neurochemistry.

[33]  M. Hyyppä,et al.  Effect of L-dopa on the hypothalamic, pineal and striatal monoamines and on the sexual behaviour of the rat. , 1971, Brain research.